id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-283968-ege0j4lf	Le Breton, C.	Extracorporeal membrane oxygenation for refractory COVID-19 acute respiratory distress syndrome	2020-07-16		.txt	text/plain	824	58	58	Recent studies suggest a survival benefit from extracorporeal membrane oxygenation (ECMO) in patients with severe acute respiratory distress syndrome (ARDS) [1, 2] . In a study on 52 critically-ill patients with SARS-CoV-2 pneumonia, six patients received ECMO of whom five died and one was still on ECMO at the time of publication [4] . In another study describing 12 critically-ill COVID-19 patients treated with ECMO, five patients died [6] . Finally, in a report on eight patients treated with ECMO, only three were weaned from the device but were still mechanically ventilated at the time of publication whereas four died and one was still receiving the technique [7]. These results tend to suggest that patients treated with ECMO during severe COVID-19 related ARDS have a poor prognosis. Median duration of mechanical ventilation before ECMO implantation was 6 days. All 13 patients were weaned from ECMO after a median of 13 days (range 3 to 34).	./cache/cord-283968-ege0j4lf.txt	./txt/cord-283968-ege0j4lf.txt